FDA Inspection
Recipharm Uppsala ABRecipharm Uppsala AB – FDA Inspection, Jun 30, 2017
Record Details
This FDA Inspection record concerns Recipharm Uppsala AB, with an inspection on June 30, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 3cf2f7c1-c42d-4c91-b17e-8bcde754b9ef
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1028387
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Recipharm Uppsala AB
3| Date | Classification | Office | Project area |
|---|---|---|---|
| April 17, 2024 | VAI | Drug Quality Assurance | |
| August 26, 2021 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 14, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Recipharm Uppsala AB
- FDA Inspection 1301930 - 2024-04-17
- FDA Inspection 1210857 - 2021-08-26
- FDA Inspection 869566 - 2014-03-14
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.